BioLight Life Sciences Ltd (BOLT) — Working Capital to Net Assets Ratio
BioLight Life Sciences Ltd (BOLT) has a Working Capital to Net Assets ratio of 55.8% as of December 2025. Working capital of ILA22.40 Million (current assets of ILA24.40 Million minus current liabilities of ILA2.00 Million) is measured against net assets of ILA40.17 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see BOLT asset base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BioLight Life Sciences Ltd Working Capital to Net Assets (2013–2025)
This chart shows how BioLight Life Sciences Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 55.8%, reflecting working capital of ILA22.40 Million against net assets of ILA40.17 Million ILA. Check BOLT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Annual Working Capital to Net Assets for BioLight Life Sciences Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BioLight Life Sciences Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore BioLight Life Sciences Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 55.8% | ILA22.40 Million | ILA40.17 Million | ILA24.40 Million | ILA2.00 Million | ▲ +15.8 pp |
| 2024 | 39.9% | ILA12.28 Million | ILA30.74 Million | ILA14.35 Million | ILA2.07 Million | ▲ +17.7 pp |
| 2023 | 22.3% | ILA6.74 Million | ILA30.30 Million | ILA9.06 Million | ILA2.31 Million | ▼ -6.6 pp |
| 2022 | 28.8% | ILA15.49 Million | ILA53.69 Million | ILA18.02 Million | ILA2.54 Million | ▼ -22.9 pp |
| 2021 | 51.8% | ILA31.79 Million | ILA61.42 Million | ILA34.00 Million | ILA2.21 Million | ▼ -29.6 pp |
| 2020 | 81.4% | ILA48.90 Million | ILA60.11 Million | ILA51.46 Million | ILA2.56 Million | ▲ +26.9 pp |
| 2019 | 54.5% | ILA37.14 Million | ILA68.15 Million | ILA40.71 Million | ILA3.57 Million | ▼ -19.4 pp |
| 2018 | 73.9% | ILA57.49 Million | ILA77.80 Million | ILA62.51 Million | ILA5.02 Million | ▼ -83.0 pp |
| 2017 | 156.9% | ILA12.60 Million | ILA8.03 Million | ILA19.86 Million | ILA7.26 Million | ▲ +16.5 pp |
| 2016 | 140.4% | ILA23.04 Million | ILA16.41 Million | ILA30.03 Million | ILA6.99 Million | ▲ +40.9 pp |
| 2015 | 99.5% | ILA46.83 Million | ILA47.06 Million | ILA53.44 Million | ILA6.61 Million | ▼ -1.0 pp |
| 2014 | 100.6% | ILA25.88 Million | ILA25.74 Million | ILA32.43 Million | ILA6.55 Million | ▲ +27.7 pp |
| 2013 | 72.9% | ILA16.11 Million | ILA22.11 Million | ILA21.01 Million | ILA4.90 Million | — |